Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K was filed on October 11, 2011, by Fresenius Medical Care AG & Co. KGaA, a German partnership limited by shares. The filing serves to disclose an investor news release issued on October 10, 2011, regarding a specific financing transaction.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data for the period. The primary financial disclosure relates to the pricing of euro-denominated floating-rate senior notes. Specific details regarding the total principal amount, interest rate, maturity date, or use of proceeds are not included in the provided text.
Material Changes
The material change disclosed is the execution of a new debt instrument. The Company announced the pricing of euro-denominated floating-rate senior notes. No comparative financial performance data against prior periods is available in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary on future guidance, operational outlook, or specific risk factors beyond the standard disclosure of the debt issuance. No unusual items or contingencies are described in the provided text.
Investor Verification Checklist
- Verify the total principal amount of the senior notes issued on October 10, 2011.
- Confirm the specific floating-rate benchmark and margin applicable to the new debt.
- Identify the maturity date and any call provisions associated with the senior notes.
- Determine the intended use of proceeds from this financing transaction.
- Review the full text of Exhibit 99.1 (Investor News Release) for complete transaction details.